Your browser doesn't support javascript.
loading
Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies.
Sanguedolce, Francesco; Sancho Pardo, Gemma; Mercadé Sanchez, Asier; Balaña Lucena, Josep; Pisano, Francesca; Cortez, Julio Calderón; Territo, Angelo; Huguet Perez, Jordi; Gaya Sopeña, Josep; Esquina Lopez, Cristina; Breda, Alberto; Palou Redorta, Joan.
Afiliação
  • Sanguedolce F; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Sancho Pardo G; Department of Radiation Oncology, Hospital Sant Pau i de la Santa Creu, Autonomous University of Barcelona, Spain.
  • Mercadé Sanchez A; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Balaña Lucena J; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Pisano F; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Cortez JC; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Territo A; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Huguet Perez J; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Gaya Sopeña J; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Esquina Lopez C; Research Institute-Statistics Section, Vall d'Hebron Hospital, Barcelona, Spain.
  • Breda A; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
  • Palou Redorta J; Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, Spain.
Prostate Int ; 9(1): 48-53, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33912514
ABSTRACT

BACKGROUND:

Late onset of radiation-induced haemorrhagic cystitis (RHC) after radiation therapy (RT) for prostate cancer (PCa) may present or evolve severely, requiring hospitalization with invasive interventions. In the present study, we have analysed the prevalence and risk factors associated with the onset of RHC.

METHODS:

From January 2002 to May 2017, 1421 patients undertook RT for PCa as a primary, adjuvant, or salvage treatment option. RHC presented in 5.6% (n = 80) of the patients; the diagnosis was based on clinical and endoscopic characteristics. Variables in observation included patients, tumours, and RT-dosimetry characteristics. Patients with a previous history of bladder cancer were excluded. Univariate (Student t/Chi square) and uni-/multivariate Cox regression analysis were performed; the events and time-points were hospitalization and time-to-event, respectively.

RESULTS:

There were 80 patients with a mean age at RT of 70.1 years (SD 6.4), mean time lag to RHC of 43.9 months (SD 37.5). Median Emergency attendance was two and three times for patients without/with hospitalization, respectively. There were in total 64 admissions with invasive treatment required in 26/36 (72.2%) of the patients hospitalised, including transurethral fulguration in 22 and radical cystectomy in 5. Patients at higher risk of hospitalization were those undertaking antiplatelet/anticoagulant treatment (HR3.30; CI 95%1.53-3.30; p = 0.002) and those treated with salvage RT with higher bladder volume receiving >70 Gy (bladder V70) (HR1.03; CI 95%1.01-1.05; p = 0.027). At receiving operating characteristic analysis, the cutoff for bladder V70 was 29%.

CONCLUSION:

Nearly half of patients presenting RHC may require invasive treatment including cystectomy. Risk factors associated with hospitalization are patients undertaking antiplatelet/coagulant treatment and bladder V70 > 29% in salvage RT patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article